1-anilino-8-naphthalenesulfonate has been researched along with Cardiac Failure in 17 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dark red nodules that drained an opaque amber liquid developed on the extensor surfaces of both legs in a 69-year-old woman receiving furosemide and spironolactone for congestive heart failure." | 3.65 | Panniculitis of the legs with urate crystal deposition. ( Niemi, KM, 1977) |
| "To induce a pathological type of cardiac hypertrophy we infused angiotensin II (AngII) for 2 days via osmotic mini pumps in control and tamoxifen-inducible, cardiomyocyte (CM)-specific p38 MAPKα KO mice (iCMp38αKO) and assessed cardiac function by echocardiography, complemented by transcriptomic, histological, and immune cell analysis." | 1.72 | Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development. ( Bottermann, K; Deenen, R; Fischer, JW; Gödecke, A; Grandoch, M; Harris, TE; Hemmers, A; Herebian, D; Kalfhues, L; Köhrer, K; Leitner, LM; Nederlof, R; Nemmer, J; Oenarto, V; Petzsch, P; Pfeffer, M; Raje, V; Reichert, AS; Stegbauer, J; Zabri, H, 2022) |
| "Atglistatin treatment led to a dramatic reduction of these pro-fibrotic and pro-apoptotic processes." | 1.72 | Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage. ( Bartolomaeus, H; Beyhoff, N; Breinbauer, R; Foryst-Ludwig, A; Grabner, GF; Grune, J; Kershaw, EE; Kintscher, U; Klopfleisch, R; Luettges, K; Migglautsch, AK; Ritter, D; Rothe, M; Schupp, M; Smeir, E; Steinhoff, JS; Thiele, A; Wilck, N; Zechner, R, 2022) |
| "Pressure overload-induced cardiac hypertrophy was generated in endothelial lipase(-/-) and wild-type mice by ascending aortic banding." | 1.39 | Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake. ( Hara, T; Hirata, K; Ishida, T; Kawai, H; Mori, K; Nakajima, H; Sasaki, N; Satomi-Kobayashi, S; Tanaka, H; Toh, R; Yasuda, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bottermann, K | 1 |
| Kalfhues, L | 1 |
| Nederlof, R | 1 |
| Hemmers, A | 1 |
| Leitner, LM | 1 |
| Oenarto, V | 1 |
| Nemmer, J | 1 |
| Pfeffer, M | 1 |
| Raje, V | 1 |
| Deenen, R | 1 |
| Petzsch, P | 1 |
| Zabri, H | 1 |
| Köhrer, K | 1 |
| Reichert, AS | 1 |
| Grandoch, M | 1 |
| Fischer, JW | 1 |
| Herebian, D | 1 |
| Stegbauer, J | 1 |
| Harris, TE | 1 |
| Gödecke, A | 1 |
| Thiele, A | 1 |
| Luettges, K | 1 |
| Ritter, D | 1 |
| Beyhoff, N | 2 |
| Smeir, E | 2 |
| Grune, J | 2 |
| Steinhoff, JS | 1 |
| Schupp, M | 1 |
| Klopfleisch, R | 2 |
| Rothe, M | 2 |
| Wilck, N | 1 |
| Bartolomaeus, H | 1 |
| Migglautsch, AK | 2 |
| Breinbauer, R | 2 |
| Kershaw, EE | 3 |
| Grabner, GF | 1 |
| Zechner, R | 4 |
| Kintscher, U | 2 |
| Foryst-Ludwig, A | 2 |
| Potočnjak, I | 1 |
| Trbušić, M | 1 |
| Terešak, SD | 1 |
| Radulović, B | 1 |
| Pregartner, G | 1 |
| Berghold, A | 1 |
| Tiran, B | 1 |
| Marsche, G | 1 |
| Degoricija, V | 1 |
| Frank, S | 1 |
| Salatzki, J | 1 |
| Bentele, K | 1 |
| Blumrich, A | 1 |
| Ban, Z | 1 |
| Brix, S | 1 |
| Dunst, S | 1 |
| Surma, MA | 1 |
| Klose, C | 1 |
| Heinzel, FR | 1 |
| Krannich, A | 1 |
| Beule, D | 1 |
| Schulze, PC | 1 |
| Marx, N | 1 |
| Parajuli, N | 1 |
| Takahara, S | 1 |
| Matsumura, N | 1 |
| Kim, TT | 1 |
| Ferdaoussi, M | 1 |
| Dyck, JRB | 1 |
| Zhou, H | 1 |
| Lei, X | 1 |
| Yan, Y | 1 |
| Lydic, T | 1 |
| Li, J | 1 |
| Weintraub, NL | 1 |
| Su, H | 1 |
| Chen, W | 1 |
| Nakajima, H | 1 |
| Ishida, T | 1 |
| Satomi-Kobayashi, S | 1 |
| Mori, K | 1 |
| Hara, T | 1 |
| Sasaki, N | 1 |
| Yasuda, T | 1 |
| Toh, R | 1 |
| Tanaka, H | 1 |
| Kawai, H | 1 |
| Hirata, K | 1 |
| Schlueter, N | 1 |
| Birkenfeld, AL | 1 |
| Schrammel, A | 1 |
| Mussbacher, M | 1 |
| Wölkart, G | 1 |
| Stessel, H | 1 |
| Pail, K | 1 |
| Winkler, S | 1 |
| Schweiger, M | 1 |
| Haemmerle, G | 2 |
| Al Zoughbi, W | 1 |
| Höfler, G | 1 |
| Lametschwandtner, A | 1 |
| Mayer, B | 1 |
| Han, D | 1 |
| Choi, R | 1 |
| Hyun, C | 1 |
| Higashi, M | 1 |
| Hirano, K | 2 |
| Kobayashi, K | 2 |
| Ikeda, Y | 2 |
| Issiki, A | 1 |
| Otsuka, T | 1 |
| Suzuki, A | 1 |
| Yamaguchi, S | 1 |
| Zaima, N | 2 |
| Hamada, S | 1 |
| Hanada, H | 1 |
| Suzuki, C | 1 |
| Nakamura, H | 1 |
| Nagasaka, H | 1 |
| Miyata, T | 1 |
| Miyamoto, Y | 1 |
| Naito, H | 1 |
| Toda, T | 1 |
| Sakata, Y | 1 |
| Matsumiya, G | 1 |
| RAO, R | 1 |
| CHITRA, DR | 1 |
| LAKSHMINARAYANA, G | 1 |
| Lass, A | 1 |
| Zimmermann, R | 1 |
| Gorkiewicz, G | 1 |
| Meyer, C | 1 |
| Rozman, J | 1 |
| Heldmaier, G | 1 |
| Maier, R | 1 |
| Theussl, C | 1 |
| Eder, S | 1 |
| Kratky, D | 1 |
| Wagner, EF | 1 |
| Klingenspor, M | 1 |
| Hoefler, G | 1 |
| Niemi, KM | 1 |
| Gostomzyk, JG | 1 |
| Frei, GF | 1 |
| Vinci, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Metabolic Signalling in Muscle- and Adipose Tissue Following Insulin Withdrawal and Growth Hormone Injection in Type I Diabetes Mellitus, a Clinical Experimental Study.[NCT02077348] | 9 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
| The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study[NCT02157155] | 9 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
17 other studies available for 1-anilino-8-naphthalenesulfonate and Cardiac Failure
| Article | Year |
|---|---|
Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.
Topics: Adipose Tissue; Angiotensin II; Animals; Cardiomegaly; Fatty Acids; Heart Failure; Inflammation; Lip | 2022 |
Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage.
Topics: Adipose Tissue; Adrenergic Agents; Animals; Catecholamines; Heart Failure; Lipase; Lipolysis; Male; | 2022 |
Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Humans; Lipase; Lipids; Lipoproteins; Male; Metaboli | 2017 |
Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
Topics: Adipose Tissue; Animals; Case-Control Studies; Cells, Cultured; Heart Failure; Humans; Hypertension; | 2018 |
Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.
Topics: Adipocytes; Animals; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Heart Failure; | 2018 |
Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
Topics: Adipocytes; Adipose Tissue; Animals; Cardiomyopathies; Cell Differentiation; Disease Models, Animal; | 2019 |
Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Anim | 2013 |
How high-density lipoprotein fuels the failing heart.
Topics: Animals; Blood Pressure; Fatty Acids; Heart Failure; Hypertension; Lipase; Signal Transduction | 2013 |
Endothelial dysfunction in adipose triglyceride lipase deficiency.
Topics: Adipose Tissue; Animals; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Fail | 2014 |
Canine pancreatic-specific lipase concentrations in dogs with heart failure and chronic mitral valvular insufficiency.
Topics: Animals; Case-Control Studies; Dog Diseases; Dogs; Heart Failure; Lipase; Mitral Valve Insufficiency | 2015 |
Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase.
Topics: Cardiomyopathy, Dilated; Female; Heart Failure; Homozygote; Humans; Japan; Lipase; Male; Mutation; P | 2015 |
Triglyceride deposit cardiomyovasculopathy.
Topics: Adult; Biopsy; Cholesterol; Coronary Vessels; Heart Failure; Humans; Lipase; Male; Muscle, Skeletal; | 2008 |
SERUM TRIBUTYRINASE LEVELS IN HEALTH AND DISEASE.
Topics: Anemia; Anemia, Macrocytic; Clinical Enzyme Tests; Diabetes Mellitus; Dyspepsia; Female; Glomerulone | 1963 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Panniculitis of the legs with urate crystal deposition.
Topics: Aged; Arthritis; Diagnosis, Differential; Female; Furosemide; Gout; Heart Failure; Humans; Lipase; S | 1977 |
[Unesterified free fatty acids in the serum and agonal circulatory failure].
Topics: Adenylyl Cyclases; Asphyxia; Catecholamines; Cholesterol; Craniocerebral Trauma; Fatty Acids; Fatty | 1970 |
[Lipase activity in the normal and pathological placenta (biochemical determination of placental lipase)].
Topics: Adult; Erythroblastosis, Fetal; Female; Heart Failure; Humans; Kidney Diseases; Lipase; Placenta; Pr | 1967 |